Currently recommended treatments of childhood constipation are not evidence based: a systematic literature review on the effect of laxative treatment and dietary measures.
BACKGROUND
Constipation is a common complaint in children and early intervention with oral laxatives may improve complete resolution of functional constipation. However, most treatment guidelines are based on reviews of the literature that do not incorporate a quality assessment of the studies.


OBJECTIVE
To investigate and summarise the quantity and quality of the current evidence for the effect of laxatives and dietary measures on functional childhood constipation.


METHODS
The Medline and Embase databases were searched to identify studies evaluating the effect of a medicamentous treatment or dietary intervention on functional constipation. Methodological quality was assessed using a validated list of criteria. Data were statistically pooled, and in case of clinical heterogeneity results were summarised according to a best evidence synthesis.


RESULTS
Of the 736 studies found, 28 met the inclusion criteria. In total 10 studies were of high quality. The included studies were clinically and statistically heterogeneous in design. Most laxatives were not compared to placebo. Compared to all other laxatives, polyethylene glycol (PEG) achieved more treatment success (pooled relative risk (RR): 1.47; 95% CI 1.23 to 1.76). Lactulose was less than or equally effective in increasing the defecation frequency compared to all other laxatives investigated. There was no difference in effect on defecation frequency between fibre and placebo (weighted standardised mean difference 0.35 bowel movements per week in favour of fibre, 95% CI -0.04 to 0.74).


CONCLUSIONS
Insufficient evidence exists supporting that laxative treatment is better than placebo in children with constipation. Compared to all other laxatives, PEG achieved more treatment success, but results on defecation frequency were conflicting. Based on the results of this review, we can give no recommendations to support one laxative over the other for childhood constipation.
Pijpers
M A M
MA
Department of General Practice, Room Ff323, Erasmus Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands. m.pijpers@erasmusmc.nl
Tabbers
M M
MM
Benninga
M A
MA
Berger
M Y
MY
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003248:Constipation / Q000178:diet therapy / Q000188:drug therapy*; D018849:Controlled Clinical Trials as Topic / Q000592:standards; D019317:Evidence-Based Medicine; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007792:Lactulose / Q000627:therapeutic use; D054368:Laxatives / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011785:Quality Assurance, Health Care
D054368:Laxatives; D011092:Polyethylene Glycols; D007792:Lactulose